Michael C. Gibson
Amministratore Delegato presso The Baim Institute for Clinical Research
Profilo
Michael C.
Gibson is currently the President & Chief Executive Officer at The Baim Institute for Clinical Research.
Prior to this, he was a Professor & Chairman-PERFUSE Study Group at Harvard Medical School from 2012.
He completed his undergraduate, graduate, and doctorate degrees from The University of Chicago.
Posizioni attive di Michael C. Gibson
| Società | Posizione | Inizio |
|---|---|---|
The Baim Institute for Clinical Research
 The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Amministratore Delegato | - |
| Harvard Medical School | Corporate Officer/Principal | 01/01/1987 |
Formazione di Michael C. Gibson
| The University of Chicago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
The Baim Institute for Clinical Research
The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Commercial Services |
- Borsa valori
- Insiders
- Michael C. Gibson